Small Solute Clearance in Peritoneal Dialysis
Kannaiyan S. Rabindranath
Renal Unit, Waikato Hospital, Hamilton, New Zealand
Search for more papers by this authorSharon J. Nessim
Division of Nephrology, Jewish General Hospital, McGill University, Montreal, Canada
Search for more papers by this authorJoanne M. Bargman
Department of Medicine, Division of Nephrology, University of Toronto, Toronto, Canada
Search for more papers by this authorKannaiyan S. Rabindranath
Renal Unit, Waikato Hospital, Hamilton, New Zealand
Search for more papers by this authorSharon J. Nessim
Division of Nephrology, Jewish General Hospital, McGill University, Montreal, Canada
Search for more papers by this authorJoanne M. Bargman
Department of Medicine, Division of Nephrology, University of Toronto, Toronto, Canada
Search for more papers by this authorJonathan C. Craig MBChB, DipCH, MMed(Clin Epi), PhD, FAHMS
Matthew Flinders Distinguished Professor Vice President and Executive Dean
College of Medicine and Public Health, Flinders University, Adelaide, Australia
Search for more papers by this authorDonald A. Molony MD
Professor of Medicine Distinguished Teaching Professor of the University of Texas System
Division of Renal Diseases and Hypertension AND Center for Clinical Research and Evidence-based Medicine, McGovern Medical School University of Texas, Houston, TX, USA
Search for more papers by this authorGiovanni F.M. Strippoli MD, PhD, MPH, MM (Epi)
Professor of Nephrology Adjunct Professor of Epidemiology
Department of Emergency and Organ Transplantation – University of Bari, Bari, Italy
School of Public Health, University of Sydney, Sydney, NSW, Australia
Search for more papers by this authorSummary
The ideal method of assessing the adequacy of peritoneal dialysis (PD) has yet to be determined. While measures of solute clearance have traditionally focused on small solutes such as urea and creatinine, little attention has been paid to clearance of larger molecular weight uremic toxins, the so-called “middle molecules” and protein-bound uremic toxins which may have important pathophysiological impacts on mortality and morbidity. The peritoneum is a serous semipermeable membrane composed of a thin layer of connective tissue covered by a mesothelial cell monolayer. The peritoneal equilibration test is the most widely used test to characterize the rate of solute and water transfer in patients undergoing PD. The routine measurement of small solute clearance serves to screen patients for evidence of underdialysis. Aminoglycosides are frequently used to treat peritonitis in PD patients because of their effectiveness as bactericidal agents and the ease of intraperitoneal administration.
References
- Paniagua , R. , Amato , D. , Vonesh , E. et al. ( 2002 ). Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial . J. Am. Soc. Nephrol. 13 ( 5 ): 1307 – 1320 .
- Lo , W.K. , Ho , Y.W. , Li , C.S. et al. ( 2003 ). Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized, prospective study . Kidney Int. 64 ( 2 ): 649 – 656 .
- Rumpsfeld , M. , McDonald , S. , and Johsnon , D.W. ( 2009 ). Peritoneal small solute clearance is nonlinearly related to patient survival in the Australian and New Zealand peritoneal dialysis patient populations . Perit. Dial. Int. 29 ( 6 ): 637 – 646 .
- Fried , L. , Hebah , N. , Finkelstein , F. , and Piraino , B. ( 2008 ). Association of Kt/V and creatinine clearance with outcomes in anuric peritoneal dialysis patients . Am. J. Kidney Dis. 52 ( 6 ): 1122 – 1130 .
- Lo , W.K. , Lui , S.L. , Chan , T.M. et al. ( 2005 ). Minimal and optimal peritoneal Kt/V targets: results of an anuric peritoneal dialysis patient's survival analysis . Kidney Int. 67 ( 5 ): 1032 – 1038 .
- Zhang , L. , Zeng , X. , Fu , P. , and Wu , H.M. ( 2014 ). Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients . Cochrane Database Syst. Rev. ( 6 ) (Art. No.: CD009120). DOI: https://doi.org/10.1002/14651858.CD009120.pub2 . Accessed online 8 August 2018.
- Rabindranath , K.S. , Adams , J. , Ali , T.Z. et al. ( 2007 ). Continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis for end-stage renal disease . Cochrane Database Syst. Rev. ( 2 ) (Art. No.: CD006515). DOI: https://doi.org/10.1002/14651858.CD0065 . Accessed online 8 August 2018.
- Medcalf , J.F. , Harris , K.P.G. , and Walls , J. ( 2001 ). Role of diuretics in the preservation of residual kidney function in patients on continuous ambulatory peritoneal dialysis . Kidney Int. 59 ( 3 ): 1128 – 1133 .
- Lui , S.L. , Cheng , S.W. , Ng , F. et al. ( 2005 ). Cefazolin plus netilimicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual kidney function . Kidney Int. 68 ( 5 ): 2375 – 2380 .
- Shemin , D. , Maaz , D. , St. Pierre , D. et al. ( 1999 ). Effect of aminoglycoside use of residual kidney function in peritoneal dialysis patients . Am. J. Kidney Dis. 34 ( 1 ): 14 – 20 .
- Singhal , M.K. , Bhaskaran , S. , Vidgen , E. et al. ( 2000 ). Rate of decline of residual kidney function in patients on peritoneal dialysis and the factors affecting it . Perit. Dial. Int. 20 ( 4 ): 429 – 438 .
- Baker , R.J. , Senior , H. , Clemenger , M. , and Brown , E.A. ( 2003 ). Empirical aminoglycosides for peritonitis do not affect residual kidney function . Am. J. Kidney Dis. 41 ( 3 ): 670 – 675 .
- Badve , S. , Hawley , C.M. , McDonald , S.P. et al. ( 2012 ). Use of aminoglycosides for peritoneal dialysis-associated peritonitis does not affect residual kidney function . Nephrol. Dial. Transplant. 27 ( 1 ): 381 – 387 .
- Jian , N. , Qian , J. , Sun , W. et al. ( 2009 ). Better preservation of residual kidney function in peritoneal dialysis patients treated with a low-protein diet supplemented with keto-acids: a prospective, randomized trial . Nephrol. Dial. Transplant. 24 ( 8 ): 2551 – 2558 .
- Hultcrantz , M. , Rind , D. , Akl , E.A. et al. ( 2017 ). The GRADE Working Group clarifies the construct of certainty of evidence . J. Clin. Epidemiol. 87 : 4 – 13 .
- Lowrie , E. , Laird , N. , Parker , T. , and Sargent , J.A. ( 1981 ). Effect of the hemodialysis prescription on patient morbidity: report from the National Cooperative Dialysis Study (NCDS) . N. Engl. J. Med. 305 ( 20 ): 1176 – 1181 .
- Gotch , F.A. and Sargent , J.A. ( 1985 ). A mechanistic analysis of the National Cooperative Dialysis Study (NCDS) . Kidney Int. 28 ( 3 ): 526 – 534 .
- Popovich , R.P. , Moncrief , J. , Nolph , K.D. et al. ( 1978 ). Continuous ambulatory peritoneal dialysis . Ann. Int. Med. 88 ( 4 ): 449 – 456 .
- Chan , C.T. , Blankestijn , P.J. , Dember , L.M. et al. ( 2019 ). Dialysis initiation, modality choice, access and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference . Kidney Int. 96 : 37 – 47 .
- Watson , P.E. , Watson , I.D. , and Batt , R.D. ( 1980 ). Total body water volumes for adult males and females estimated from simple anthropometric measurements . Am. J. Clin. Nutr. 33 ( 1 ): 27 .
- Dubois , D. and Dubois , E.F. ( 1916 ). A formula to estimate the approximate surface area if height and weight be known . Arch. Intern. Med. 17 : 863 .
- Bello K , Levin A , Lunney M , et al. International Society of Nephrology Global Kidney Health Atlas 2019 . https://www2.theisn.org/GKHA (accessed 13 January 2020).
- Wang , A. , Zhao , J. , Bieber , B. et al. ( 2020 ). International comparison of peritoneal dialysis prescriptions from the Peritoneal Dialysis Outcomes and Practice Patter Study . Perit. Dial. Int. 40 ( 3 ); 310 – 319 .
- Gotloib , L. and Shostak , A. ( 1987 ). Ultrastructural morphology of the peritoneum: new findings and speculations on transfer of solutes and water during peritoneal dialysis . Perit. Dial. Bull. 7 : 119 – 129 .
- Gotloib , L. ( 1982 ). Anatomy of the peritoneal membrane . In: Ronco Peritoneal Dialysis (eds. G. La , G. Greca and G. Biasioli ), 17 – 30 . Wichtig Editore , Milan .
- Rippe , B. and Stelin , G. ( 1989 ). Simulations of peritoneal solute transport during CAPD: application of two-pore formalism . Kidney Int. 35 : 1234 – 1244 .
- Pannekeet , M.M. , Mulder , J.B. , Weening , J.J. et al. Demonstration of aquaporin-CHIP in peritoneal tissue of uremic and CAPD patients . Perit. Dial. Int. 16 ( Suppl 1 ): S54 – S57 .
- Rippe , B. , Simonsen , O. , and Stelin , G. ( 1991 ). Clinical implications of a three-pore model of peritoneal transport . Adv. Perit. Dial. 7 : 3 – 9 .
- Leypoldt , J.K. , Parker , H.R. , Frigon , R.P. , and Henderson , L.W. ( 1987 ). Molecular size dependence of peritoneal transport . J. Lab. Clin. Med. 110 : 207 – 216 .
- Twardowski , Z.J. , Nolph , K.D. , Khanna , R. et al. ( 1987 ). Peritoneal equilibration test . Perit. Dial. Bull. 7 : 138 – 148 .
- Canada-USA (CANUSA) Peritoneal Dialysis Study Group ( 1996 ). Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes . J. Am. Soc. Nephrol. 7 ( 2 ): 198 – 207 .
- Bargman , J.M. , Thorpe , K.E. , and Churchill , D.N. and the CANUSA Peritoneal Dialysis Study Group ( 2001 ). Relative contribution of residual kidney function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study . J. Am. Soc. Nephrol. 12 ( 10 ): 2158 – 2162 .
- Szeto , C.C. , Wong , T.Y. , Chow , K.M. et al. ( 2001 ). Impact of dialysis adequacy on the mortality and morbidity of anuric Chinese patients receiving continuous ambulatory peritoneal dialysis . J. Am. Soc. Nephrol. 12 ( 2 ): 355 – 360 .
- Jansen , M.A. , Termoshuizen , F. , Korevaar , J.C. et al. ( 2005 ). Predictors of survival in anuric peritoneal dialysis patients . Kidney Int. 68 ( 3 ): 1199 – 1205 .
- Maiorca , R. , Brunori , G. , Zubani , R. et al. ( 1995 ). Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study . Nephrol. Dial. Transplant. 10 ( 12 ): 2295 – 2305 .
- Genestier , S. , Hedelin , G. , Schaffer , P. , and Faller , B. ( 1995 ). Prognostic factors in CAPD patients: a retrospective study of a 10-year period . Nephrol. Dial. Transplant. 10 ( 10 ): 1905 – 1911 .
- Diaz-Buxo , J.A. , Lowrie , E.G. , Lew , N.L. et al. ( 1999 ). Associates of mortality among peritoneal dialysis patients with special reference to peritoneal transport rates and solute clearance . Am. J. Kidney Dis. 33 ( 3 ): 523 – 534 .
- Rocco , M. , Soucie , J.M. , Pastan , S. , and McClellan , W.M. ( 2000 ). Peritoneal dialysis adequacy and risk of death . Kidney Int. 58 ( 1 ): 446 – 457 .
-
Szeto , C.C.
,
Wong , T.Y.
,
Chow , K.M.
et al. (
2004
).
Independent effects of renal and peritoneal creatinine clearances on the mortality of peritoneal dialysis patients
.
Perit. Dial. Int.
4
(
1
):
58
–
64
.
10.1177/089686080402400106 Google Scholar
- Szeto , C.C. , Wong , T.Y. , Leung , C.B. et al. ( 2000 ). Importance of dialysis adequacy in mortality and morbidity of Chinese CAPD patients . Kidney Int. 58 ( 1 ): 400 – 407 .
- Wang , A.Y. , Wang , M. , Woo , J. et al. ( 2004 ). Inflammation, residual kidney function, and cardiac hypertropthy are interrelated and combine adversely to enhance mortality an cardiovascular death risk of peritoneal dialysis patients . J. Am. Soc. Nephrol. 15 ( 8 ): 2186 – 2194 .
- Rocco , M.V. , Frankenfield , D.L. , Prowant , B. et al.; Centers for Medicare & Medicaid Services Peritoneal Dialysis Core Indicators Study Group ( 2002 ). Risk factors for early mortality in U.S. peritoneal dialysis patients: impact of residual kidney function . Perit. Dial. Int. 22 ( 3 ): 371 – 379 .
- Chung , S.H. , Heimburger , O. , Stenvinkel , P. et al. ( 2003 ). Association between residual kidney function, inflammation and patient survival in new peritoneal dialysis patients . Nephrol. Dial. Transplant. 18 ( 3 ): 590 – 597 .
- Ates , K. , Nergizolglu , G. , Keven , K. et al. ( 2001 ). Effect of fluid and sodium removal on mortality in peritoneal dialysis patients . Kidney Int. 60 ( 2 ): 767 – 776 .
- Lo , W.K. , Tong , K.L. , Li , C.S. et al. ( 2001 ). Relationship between adequacy of dialysis and nutritional status, and their impact on patient survival on CAPD in Hong Kong . Perit. Dial. Int. 21 ( 5 ): 441 – 447 .
- Chung , S.H. , Heimburger , O. , Stenvinkel , P. et al. ( 2003 ). Influence of peritoneal transport rate, inflammation, and fluid removal on nutritional status and clinical outcome in prevalent peritoneal dialysis patients . Perit. Dial. Int. 23 ( 2 ): 174 – 183 .
- Termorshuizen , F. , Korevaar , J.C. , Dekker , F.W. et al. ( 2003 ). The relative importance of residual kidney function compared peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2 . Am. J. Kidney Dis. 41 ( 6 ): 1293 – 1302 .
- Jager , K.J. , Merkus , M.P. , Dekker , F.W. et al. ( 1999 ). Mortality and technique failure in patients starting chronic peritoneal dialysis: results of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD) . Kidney Int. 55 ( 4 ): 1476 – 1485 .
- Davies , S.J. , Phillips , L. , and Russell , G.I. ( 1998 ). Peritoneal solute transport predicts survival on CAPD independently of residual kidney function . Nephrol. Dial. Transplant. 13 ( 4 ): 962 – 968 .
- Park , H.C. , Kang , S.W. , Choi , K.H. et al. ( 2001 ). Clinical outcome in continuous ambulatory peritoneal dialysis patients is not influenced by high transport status . Perit. Dial. Int. 21 ( Suppl 3 ): S80 – S85 .
- Bhaskaran , S. , Schaubel , D.E. , Jassal , S.V. et al. ( 2000 ). The effect of small solute clearances on survival of anuric peritoneal dialysis patients . Perit. Dial. Int. 20 ( 2 ): 181 – 187 .
- Brown , E.A. , Davies , S.J. , Rutherford , P. et al. ( 2003 ). Survival of functionally anuric patients on automated peritoneal dialysis: The European APD Outcome Study . J. Am. Soc. Nephrol. 14 ( 11 ): 2948 – 2957 .
- Menon , M.K. , Naimark , D.M. , Bargman , J.M. et al. ( 2001 ). Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual kidney function . Nephrol. Dial. Transplant. 16 ( 11 ): 2207 – 2213 .
- Wang , A.Y. , Wang , M. , Woo , J. et al. ( 2002 ). A novel association between residual kidney function and left ventricular hypertrophy in peritoneal dialysis patients . Kidney Int. 62 ( 2 ): 639 – 647 .
- Wang , A.Y. , Wang , M. , Woo , J. et al. ( 2004 ). Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients . J. Am. Soc. Nephrol. 15 ( 8 ): 2186 – 2194 .
- Bammens , B. , Evenepoel , P. , Verbeke , K. , and Vanrenterghem , Y. ( 2003 ). Removal of middle molecules and protein bound solutes by peritoneal dialysis and relation with uremic symptoms . Kidney Int. 64 ( 6 ): 2238 – 2243 .
- Bammens , B. , Evenepoel , P. , Verbeke , K. , and Vanrenterghem , Y. ( 2005 ). Time profiles of peritoneal and renal clearances of different uremic solutes in incident peritoneal dialysis patients . Am. J. Kidney Dis. 46 ( 3 ): 512 – 519 .
- Monitini , G. , Amici , G. , Milan , S. et al. ( 2002 ). Middle molecule and small protein removal in children on peritoneal dialysis . Kidney Int. 61 ( 3 ): 1153 – 1159 .
- Brown , E.A. , Blake , P.G. , Boudville , N. et al. ( 2020 ). International Society for Peritoneal Dialysis practice recommendations: prescribing high-quality goal-directed peritoneal dialysis . Perit. Dial. Int . 40 ( 3 ): 244 – 253 .
- KDOQI Guidelines ( 2006 ). Clinical practice recommendations for peritoneal dialysis adequacy . Am. J. Kidney Dis. 48 ( 1 Suppl 1 ): S98 – S129 .
- Renal Association UK guidelines ( 2017 ). Renal Association Clinical Practice Guideline on peritoneal dialysis in adults and children . BMC Nephrol. 18 : 333 . https://doi.org/10.1186/s12882-017-0687-2 .
- Blake , P.G. , Bargman , J.M. , Brimble , K.S. et al. ( 2011 ). Clinical Practice Guidelines and recommendations on peritoneal dialysis adequacy 2011 . Perit. Dial. Int. 31 ( 2 ): 218 – 239 .
- ( 2005 ). European best practice guidelines-adequacy of peritoneal dialysis . Nephrol. Dial. Transplant. 20 ( Suppl 9 ): ix24 – ix27 .
- Krediet , R.T. , Douma , C.E. , van Olden , R.W. et al. ( 1998 ). Augmenting solute clearance in peritoneal dialysis . Kidney Int. 54 ( 6 ): 2218 – 2225 .
- Blake , P. , Burkart , J.M. , Churchill , D.N. et al. ( 1996 ). Recommended clinical practices for maximizing peritoneal dialysis clearances . Perit. Dial. Int. 16 ( 5 ): 448 – 456 .
- Krediet , R.T. , Boeschoten , E.W. , Struijk , D.G. , and Arisz , L. ( 1988 ). Differences in the peritoneal transport of water, solutes and proteins between dialysis with two- and with three-litre exchanges . Nephrol. Dial. Transplant. 3 ( 2 ): 198 – 204 .
- Wang , T. , Heimbürger , O. , Cheng , H. et al. ( 1997 ). Effect of increased dialysate fill volume on peritoneal fluid and solute transport . Kidney Int. 52 ( 4 ): 1068 – 1076 .
- Chagnac , A. , Herskovitz , P. , Ori , Y. et al. ( 2002 ). Effect of increased dialysate volume on peritoneal surface area among peritoneal dialysis patients . J. Am. Soc. Nephrol. 13 ( 10 ): 2554 – 2559 .
- Aranda , R.A. , Romao Junior , J.E. , Kakehashi , E. et al. ( 2000 ). Intraperitoneal pressure and hernias in children on peritoneal dialysis . Pediatr. Nephrol. 14 ( 1 ): 22 – 24 .
- Hussain , S.I. , Bernardini , J. , and Piraino , B. ( 1998 ). The risk of hernia with large exchange volumes . Adv. Perit. Dial. 14 : 105 – 107 .
- Del Peso , G. , Bajo , M.A. , Costero , O. et al. ( 2003 ). Risk factors for abdominal wall complications in peritoneal dialysis patients . Perit. Dial. Int. 23 ( 3 ): 249 – 254 .
- Outerelo , M.C. , Gouveia , R. , Costa , F.T. , and Ramos , A. ( 2014 ). Intraperitoneal pressure has a prognostic impact on peritoneal dialysis patients . Perit. Dial. Int. 34 ( 6 ): 652 – 654 .
- Twardowski , Z.J. , Khanna , R. , Nolph , K.D. et al. ( 1986 ). Intraabdominal pressures during natural activities in patients treated with continuous ambulatory peritoneal dialysis . Nephron. 44 ( 2 ): 129 – 135 .
- Imholz , A. , Koomen , G. , Struijk , D. et al. ( 1993 ). Effect of an increased intraperitoneal pressure on fluid and solute transport during CAPD . Kidney Int. 44 ( 5 ): 1078 – 1085 .
- Juergensen , P.H. , Murphy , A.L. , Kliger , A.S. , and Finklestein , F.O. ( 2002 ). Increasing the dialysis volume and frequency in a fixed period of time in CPD patients: the effect on Kt/V and creatinine clearance . Perit. Dial. Int. 22 ( 6 ): 693 – 697 .
- Boen , S. ( 1961 ). Kinetics of peritoneal dialysis . Medicine 40 : 243 – 287 .
- Rodriguez-Carmona , A. and Perez , F.M. ( 2002 ). Sodium removal in patients undergoing CAPD and automated peritoneal dialysis . Perit. Dial. Int. 22 ( 6 ): 705 – 712 .
- Imholz , A. , Koomen , G. , Struijk , D. et al. ( 1993 ). Effect of dialysate osmolarity on the transport of low-molecular weight solutes and proteins during CAPD . Kidney Int. 43 ( 6 ): 1339 – 1346 .
- Ho-Dac-Panekeet , M.M. , Schouten , N. , Langedijk , M.J. et al. ( 1996 ). Peritoneal transport characteristics with glucose polymer based dialysate . Kidney Int. 50 ( 3 ): 979 – 986 .
- Davies , S.J. , Phillips , L. , Naish , P.F. , and Russell , G.I. ( 2001 ). Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis . J. Am. Soc. Nephrol. 12 ( 5 ): 1046 – 1051 .
- Davies , S.J. , Woodrow , G. , Donovan , K. et al. ( 2003 ). Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial . J. Am. Soc. Nephrol. 14 ( 9 ): 2338 – 2344 .
- Cho , Y. , Johnson , D.W. , Craig , J.C. et al. ( 2014 ). Biocompatible dialysis fluids for peritoneal dialysis . Cochrane Database Syst. Rev. ( 3 ) (Art. No.: CD007554). DOI: https://doi.org/10.1002/14651858.CD007554.pub2 .
- Perl , J. , Nessim , S. , and Bargman , J. ( 2011 ). The biocompatibility of neutral pH, low-GDP peritoneal dialysis solutions: benefit at bench, bedside, or both? Kidney Int. 79 ( 8 ): 814 – 824 .
- Moist , L.M. , Port , F.K. , Orzol , S.M. et al. ( 2000 ). Predictors of loss of residual kidney function among new dialysis patients . J. Am. Soc. Nephrol. 11 ( 3 ): 556 – 564 .
- Johnson , D.W. , Mudge , D.W. , Sturtevant , J.M. et al. ( 2003 ). Predictors of decline in residual kidney function in new peritoneal dialysis patients . Perit. Dial. Int. 23 ( 3 ): 276 – 283 .
- Li , P.K. , Chow , K.M. , Wong , T.Y. et al. ( 2003 ). Effect of an angiotensin-converting enzyme inhibitor on residual kidney function in patients receiving peritoneal dialysis. A randomized, controlled study . Ann. Intern. Med. 139 ( 2 ): 105 – 112 .
- Suzuki , H. , Kanno , Y. , Sugahara , S. et al. ( 2004 ). Effects of an angiotensin II receptor blocker, valsartan, on residual kidney function in patients on CAPD . Am. J. Kidney Dis. 43 ( 6 ): 1056 – 1064 .
- Wang , J. and Xiao , M.Y. ( 2005 ). Protective effects of valsartan on residual kidney function in patients on CAPD . Chin. J. Blood Purif. 4 ( 11 ): 605 – 606 .
- Zhong , H. , Sha , C.H. , Sui , T.L. et al. ( 2007 ). Effects of irbesartan on residual kidney function in peritoneal dialysis patients . Chin. J. Nephrol. 23 ( 7 ): 413 – 416 .
- Phakdeekitcharoen , B. and Leelasa-nguan , P. ( 2004 ). Effects of an ACE inhibitor or angiotensin receptor blocker on potassium in CAPD patients . Am. J. Kidney Dis. 44 ( 4 ): 738 – 746 .
- Reyes-Marin , F.A. , Calzada , C. , Ballesteros , A. , and Amato , D. ( 2012 ). Comparative study of enalapril vs. losartan on residual kidney function preservation in automated peritoneal dialysis. A randomized controlled study . Rev. Invest. Clin. 64 ( 4 ): 315 – 321 .
- Kolesnyk , I. , Noordzij , M. , Dekker , F.W. et al. ( 2011 ). Treatment with angiotensin II inhibitors and residual kidney function in peritoneal dialysis patients . Perit. Dial. Int. 31 ( 1 ): 53 – 59 .
- Dittrich , E. , Puttinger , H. , Schillinger , M. et al. ( 2006 ). Effect of radio contrast media on residual kidney function in peritoneal dialysis patients – a prospective study . Nephrol. Dial. Transplant. 21 ( 5 ): 1334 – 1339 .
- Moranne , O. , Willoteaux , S. , Pagniez , D. et al. ( 2006 ). Effect of iodinated contrast agents on residual kidney function in PD patients . Nephrol. Dial. Transplant. 21 ( 4 ): 1040 – 1045 .
- Szeto , C.C. , Kwan , B. , Chow , K.M. et al. ( 2015 ). Predictors of residual kidney function decline in patients undergoing continuous ambulatory peritoneal dialysis . Perit. Dial. Int. 35 : 180 – 188 .
- Liao , C.T. , Chen , Y.M. , Shiao , C.C. et al. ( 2009 ). Rate of decline of residual kidney function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis . Nephrol. Dial. Transplant. 24 ( 9 ): 2909 – 2914 .
- Perl , J. , Dember , L.M. , Bargman , J.M. et al. ( 2017 ). Clin. J. Am. Soc. Nephrol. 12 ( 5 ): 839 – 847 .